We formed a bench-to-bedside program to facilitate the interaction between basic research, neuroscience, experimental therapeutics, neuropharmacology, human laboratory studies and clinical trials for the development of novel therapeutics to treat brain disorders.

Haass-Koffler et al, Defining the role of corticotropin releasing factor binding protein in alcohol consumption. Translational Psychiatry, 2016

 

Our team is affiliated with the:

• Center of Alcohol and Addiction Studies (CAAS)
• Department of Psychiatry and Human Behavior (Alpert Medical School)
• Department of Behavioral and Social Sciences (School of Public Health)
• Center for Addiction and Disease Risk Exacerbation (CADRE)
• Department of Neuroscience